Supplementary Tables S1-S5. Table S1. Datasets used. Information provided includes data type, provider, analysis type, target region size, sequencing depth, dilution ratio, and sequencer. Table S2a. D
Cancer is a heterogeneous disease, and patient-level genetic assessments can guide therapy choice and impact prognosis. However, little is known about the impact of genetic variability within a tumor,
Details of all somatic mutations. Coding sequence mutations, amino acid changes, CADD score, ALT read counts and MAF for tumour, pre-surgery plasma, post-surgery plasma, and WBC are listed. (XLSX 42 k
